Shalender Bhasin, MD
Enriched profileProfessor of Medicine, Harvard Medical School; Director, Research Program in Men's Health, Aging and Metabolism, Brigham and Women's Hospital · Brigham and Women's Hospital
Shalender Bhasin is Professor of Medicine, Harvard Medical School; Director, Research Program in Men's Health, Aging and Metabolism, Brigham and Women's Hospital at Brigham and Women's Hospital. OpenAlex indexes 664 publications with 55,514 citations (h-index 102); ClinicalTrials.gov lists 24 registered studies with this person as an investigator. By OpenAlex citation count, this profile ranks in the top 1% of Endocrinology, Diabetes & Metabolism profiles in the findmyKOL directory.
Data verified 17 Aug 2026
Overview
Updated 27 Aug 2026
Shalender Bhasin, MD, is Professor of Medicine, Harvard Medical School at Brigham and Women's Hospital / Harvard Medical School. The public record shows 664 publications with 55,514 citations (h-index 102), centered on Endocrinology/Metabolic. It also documents an investigator role on 24 registered clinical trials, industry payments reported by 3 companies, 25 NIH-funded awards (2008–2026).
- Most recent indexed publication: 2026 · The Journal of clinical endocrinology and metabolism
- Top research focus: Endocrinology/Metabolic
- 24 registered trials on ClinicalTrials.gov
- Open Payments reporting from 3 companies
Generated from the cited public record · current as of 27 Aug 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintDrugs & molecules
across trials, industry payments and publicationsWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID; 37 in PubMed.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 27 Aug 2026
Listed as an investigator on 24 registered studies on ClinicalTrials.gov. The most recent:
- NAD Augmentation to Prevent or Reverse Alzheimer's Disease in People With Down Syndrome
Sponsor: Brigham and Women's Hospital
- Nicotinamide Mononucleotide in Patients Undergoing CABG Surgery
Sponsor: Brigham and Women's Hospital
- Tracing the Metabolic Flux of Orally Administered NAD+ Precursors
Sponsor: Metro International Biotech, LLC
Industry payments
Updated 27 Aug 2026
3 companies reported payments to CMS in program years 2022–2024. These are public disclosures, not judgments. The latest:
- Eli Lilly and CompanyProgram year20245 payments
- Besins Healthcare Ireland LimitedProgram year20236 payments$23,500openpaymentsdata.cms.gov ↗
- Novo Nordisk IncProgram year20225 payments
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Genitourinary & hormones
100%Androgen100%Testosterone Cypionate100%Part D≥16 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
Updated 27 Aug 2026
25 NIH research awards on record, funded 2008–2026 per NIH RePORTER. The latest:
- Repurposing a Reverse Transcriptase Inhibitor To Target Retrotransposons and Prevent Alzheimer's Disease in People with Down Syndrome: A Two-Phase UG3/UH3 Clinical Drug Development Program
Brigham and Women'S Hospital
FY2026$1,478,201UG3AG101657 - NAD Augmentation to Treat Diabetic Kidney Disease: A Randomized Controlled Trial
Brigham and Women'S Hospital
FY2026$314,717U01AG076789 - Boston OAIC: A Translational Approach to Function Promoting Therapies
Brigham and Women'S Hospital
FY2025$1,362,218P30AG031679
Publications
Updated 27 Aug 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- Longitudinal Changes in Sex Hormones in a Population of Older Community-dwelling Men.
The Journal of clinical endocrinology and metabolism
Article2026 - Effects of Testosterone-Augmented Multimodal Exercise Intervention in Spinal Cord Injury: A Randomized Controlled Trial.
The Journal of clinical endocrinology and metabolism
Article2026 - Mechanisms of Testosterone's Anabolic Effects on Muscle and Function: Controversies and New Insights.
Endocrine reviews
Review2026
Online presence
Updated 27 Aug 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accounts
public accounts run by this person- ResearchGate
researchgate.net/profile/Shalender-Bhasin
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →researchgate.net ↗
Mentions by others
where others cite or feature them- X / Twitter
x.com/NEJM/status/1953210731220091177
- YouTube
youtube.com/watch
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →youtube.com ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Background & recognition
Updated 27 Aug 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →physiciandirectory.brighamandwomens.org ↗
- Board Certified
Internal Medicine
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →physiciandirectory.brighamandwomens.org ↗
Editorial & leadership roles
journal and society appointments- Chair
Endocrine Society Expert Panel on Clinical Practice Guidelines for Testosterone Therapy in Men with Hypogonadism
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →academic.oup.com ↗
Awards & honors
honors on the public record- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →physiciandirectory.brighamandwomens.org ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →physiciandirectory.brighamandwomens.org ↗
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →emedevents.com ↗
Secondary affiliations
appointments beyond the home institution- Co-Director
Brigham Center for Transgender Health
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →brighamandwomens.org ↗ - Director
Boston Claude D. Pepper Older Americans Independence Center
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →pepper.bwh.harvard.edu ↗ - verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →dfhcc.harvard.edu ↗
Media & interviews
press, podcasts and appearances- ALL ME Podcast (Taylor Hooton Foundation)
Episode 6: "Anabolic Steroids: A Medical Perspective"
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →taylorhooton.org ↗ - provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →youtube.com ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Paul Ridker, MD
Brigham and Women's Hospital
Scott Solomon, MD
Brigham and Women's Hospital
Dennis Selkoe, MD
Brigham and Women's Hospital
Marc Pfeffer, MD
Brigham and Women's Hospital